LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Airway Obstruction D000402 13 associated lipids
Asbestosis D001195 8 associated lipids
Aspergillosis, Allergic Bronchopulmonary D001229 2 associated lipids
Asthma D001249 52 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Body Weight D001835 333 associated lipids
Brain Edema D001929 20 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Paruchuri S and Sjölander A Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407. 2003 J. Biol. Chem. pmid:12912998
Bannenberg G et al. Leukotriene C4 is a tight-binding inhibitor of microsomal glutathione transferase-1. Effects of leukotriene pathway modifiers. 1999 J. Biol. Chem. pmid:9890956
Garcia C et al. Effects of synthetic peptido-leukotrienes on bone resorption in vitro. 1996 J. Bone Miner. Res. pmid:8992883
Fang SH et al. Pranlukast attenuates ischemia-like injury in endothelial cells via inhibiting reactive oxygen species production and nuclear factor-kappaB activation. 2009 J. Cardiovasc. Pharmacol. pmid:19129732
Kim MH et al. Effect of leukotriene D4 on mouse embryonic stem cell migration and proliferation: involvement of PI3K/Akt as well as GSK-3β/β-catenin signaling pathways. 2010 J. Cell. Biochem. pmid:20589831
Cosentino S et al. Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction. 2014 J. Cell. Mol. Med. pmid:24909956
Geirsson A et al. Potentiating effects of pertussis toxin on leukotriene C4 induced formation of inositol phosphate and prostacyclin in human umbilical vein endothelial cells. 1998 J. Cell. Physiol. pmid:9731750
Al-Azzam N et al. Modulation of mast cell proliferative and inflammatory responses by leukotriene d4 and stem cell factor signaling interactions. 2015 J. Cell. Physiol. pmid:25161061
Li PC et al. Enhanced activity of Ca2+-activated K+ channels by 1-[2-hydroxy-3-propyl-4-[(1H-tetrazol-5-yl)butoxyl]phenyl] ethanone (LY-171883) in neuroendocrine and neuroblastoma cell lines. 2002 J. Cell. Physiol. pmid:12115725
Capra V et al. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation. 2005 J. Cell. Sci. pmid:16306225
Massoumi R and Sjölander A Leukotriene D(4) affects localisation of vinculin in intestinal epithelial cells via distinct tyrosine kinase and protein kinase C controlled events. 2001 J. Cell. Sci. pmid:11329379
Massoumi R et al. Leukotriene D(4) induces stress-fibre formation in intestinal epithelial cells via activation of RhoA and PKCdelta. 2002 J. Cell. Sci. pmid:12154081
Paruchuri S et al. Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. 2002 J. Cell. Sci. pmid:11956320
Meng XJ et al. Leukotriene D4 activates a chloride conductance in hepatocytes from lipopolysaccharide-treated rats. 1997 J. Clin. Invest. pmid:9185515
Soberman RJ and Christmas P The organization and consequences of eicosanoid signaling. 2003 J. Clin. Invest. pmid:12697726
Datta HK et al. Parathyroid hormone induces superoxide anion burst in the osteoclast: evidence for the direct instantaneous activation of the osteoclast by the hormone. 1996 J. Endocrinol. pmid:8708538
Bandeira-Melo C et al. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. 2002 J. Exp. Med. pmid:12235216
Uemura M et al. Cysteinyl leukotrienes in the bile of patients with obstructive jaundice. 2002 J. Gastroenterol. pmid:12424566
Gyömber E et al. Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat. 1996 J. Gastroenterol. Hepatol. pmid:8912128
Lefebvre B et al. Effect of 5-lipoxygenase blockade on blood pressure and acetylcholine-evoked endothelium-dependent contraction in aorta from spontaneously hypertensive rats. 2006 J. Hypertens. pmid:16331105
Woszczek G et al. IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells. 2008 J. Immunol. pmid:18490762
Thivierge M et al. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. 2000 J. Immunol. pmid:11046055
Lee SP et al. Crosstalk between prostaglandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial effects on cyclic AMP. 2009 J. Immunol. pmid:19109185
Baker N et al. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. 2009 J. Immunol. pmid:19265161
Chibana K et al. Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. 2003 J. Immunol. pmid:12682264
Boehmler AM et al. The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells. 2009 J. Immunol. pmid:19454674
Thivierge M et al. Cysteinyl-leukotriene receptor type 1 expression and function is down-regulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins. 2009 J. Immunol. pmid:19846883
Papayianni A et al. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. 1996 J. Immunol. pmid:8690917
Cummings HE et al. Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor. 2013 J. Immunol. pmid:24244016
Thivierge M et al. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. 2001 J. Immunol. pmid:11509632
Peres CM et al. Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. 2007 J. Immunol. pmid:17911632
Prinz I et al. The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta- and gamma delta effector T cells. 2005 J. Immunol. pmid:16002666
Woszczek G et al. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. 2010 J. Immunol. pmid:20083671
Dartt DA et al. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. 2011 J. Immunol. pmid:21357260
Davis HM et al. Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation. 2000 J. Immunol. Methods pmid:10854607
Mayatepek E et al. Defects in the synthesis of cysteinyl leukotrienes: a new group of inborn errors of metabolism. 2000 J. Inherit. Metab. Dis. pmid:10896305
Lee KH et al. Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera. 2002 J. Invest. Dermatol. pmid:11918713
Klegeris A and McGeer PL Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP. 2003 J. Leukoc. Biol. pmid:12629151
Spada CS et al. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. 1994 J. Leukoc. Biol. pmid:8301215
Krauss AH et al. Determination of leukotriene effects on human neutrophil chemotaxis in vitro by differential assessment of cell motility and polarity. 1994 J. Leukoc. Biol. pmid:8301217
Mayatepek E et al. Synthesis and metabolism of leukotrienes in gamma-glutamyl transpeptidase deficiency. 2004 J. Lipid Res. pmid:14754911
Ge H et al. Elucidation of signaling and functional activities of an orphan GPCR, GPR81. 2008 J. Lipid Res. pmid:18174606
Lukic A et al. Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4. 2016 J. Lipid Res. pmid:27436590
Zhang MQ et al. (Piperidinylalkoxy)chromones: novel antihistamines with additional antagonistic activity against leukotriene D4. 1995 J. Med. Chem. pmid:7608912
Zwaagstra ME et al. Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists. 1998 J. Med. Chem. pmid:9554876
Jorgensen NK et al. Role of LTD4 in the regulatory volume decrease response in Ehrlich ascites tumor cells. 1996 J. Membr. Biol. pmid:8661498
Pedersen S et al. Leukotriene D4-induced Ca2+ mobilization in Ehrlich ascites tumor cells. 1997 J. Membr. Biol. pmid:9002425
Mastrocola T et al. Volume regulation in human fibroblasts: role of Ca2+ and 5-lipoxygenase products in the activation of the Cl- efflux. 1993 J. Membr. Biol. pmid:8271272
Wang Y et al. Induction of LTD in the dentate gyrus in vitro is NMDA receptor independent, but dependent on Ca2+ influx via low-voltage-activated Ca2+ channels and release of Ca2+ from intracellular stores. 1997 J. Neurophysiol. pmid:9065852
Basavappa S et al. Swelling-induced arachidonic acid release via the 85-kDa cPLA2 in human neuroblastoma cells. 1998 J. Neurophysiol. pmid:9497423
Guo HF and Zhong Y Requirement of Akt to mediate long-term synaptic depression in Drosophila. 2006 J. Neurosci. pmid:16611817
Farias S et al. Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury. 2009 J. Neurotrauma pmid:19886806
Sundström E et al. Interactions among three classes of mediators explain antigen-induced bronchoconstriction in the isolated perfused and ventilated guinea pig lung. 2003 J. Pharmacol. Exp. Ther. pmid:12954791
Pedersen KE et al. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. 1997 J. Pharmacol. Exp. Ther. pmid:9152370
Goldhill JM et al. Neural control of mouse small intestinal longitudinal muscle: interactions with inflammatory mediators. 1995 J. Pharmacol. Exp. Ther. pmid:7616450
Underwood DC et al. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. 2000 J. Pharmacol. Exp. Ther. pmid:10734180
Gissurarson SR et al. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli. 1997 J. Pharmacol. Exp. Ther. pmid:9023290
Gorenne I et al. Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry. 1998 J. Pharmacol. Exp. Ther. pmid:9454796
Dumitriu D et al. Mechanism of action of leukotriene D4 on guinea pig tracheal smooth muscle cells: roles of Ca++ influx and intracellular Ca++ release. 1997 J. Pharmacol. Exp. Ther. pmid:9067324
Brochu-Bourque A et al. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor. 2011 J. Pharmacol. Exp. Ther. pmid:20966037
Tominaga M et al. ONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro. 1996 J. Pharmacol. Exp. Ther. pmid:8819486
Daniele S et al. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands. 2011 J. Pharmacol. Exp. Ther. pmid:21531793
Wong WS et al. Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro. 1997 J. Pharmacol. Exp. Ther. pmid:9336317
Cibulsky SM and Thompson DC Absence of tachykinin involvement in leukotriene D4 and antigen-induced contraction of guinea pig isolated bronchus. 1997 J. Pharmacol. Exp. Ther. pmid:9399982
Arakida Y et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors. 1998 J. Pharmacol. Exp. Ther. pmid:9808690
Aoki M et al. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. 2001 J. Pharmacol. Exp. Ther. pmid:11504812
Ni NC et al. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice. 2011 J. Pharmacol. Exp. Ther. pmid:21903747
Underwood DC et al. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. 1994 J. Pharmacol. Exp. Ther. pmid:8035322
Metters KM et al. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung. 1994 J. Pharmacol. Exp. Ther. pmid:8035338
Underwood DC et al. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. 1998 J. Pharmacol. Exp. Ther. pmid:9864284
Profita M et al. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. 2008 J. Pharmacol. Exp. Ther. pmid:18305014
Chan CC et al. Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor antagonists. 1994 J. Pharmacol. Exp. Ther. pmid:8014876
Aoki M et al. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs. 2001 J. Pharmacol. Exp. Ther. pmid:11259541
Oliva D et al. Correlation between leukotriene D4-induced contraction and cytosolic calcium elevation: a quantitative and simultaneous evaluation in smooth muscle. 1994 J. Pharmacol. Exp. Ther. pmid:8301553
Howell RE et al. Leukotrienes mediate antigen-induced airway hyper-reactivity in guinea pigs. 1994 J. Pharmacol. Exp. Ther. pmid:8301576
Dupré DJ et al. Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1. 2004 J. Pharmacol. Exp. Ther. pmid:14718577
Yuan YM et al. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway. 2009 J. Pharmacol. Sci. pmid:19234368
Itagaki K et al. Eicosanoid-induced store-operated calcium entry in dendritic cells. 2011 J. Surg. Res. pmid:20080257
Langer JC et al. Mast cell mediators and peritoneal adhesion formation in the rat. 1995 J. Surg. Res. pmid:7643592
Kalf GF Utility of a mouse model for studying the effects of benzene on the myeloid lineage: effects of hydroquinone on a model myeloid system. 2000 J. Toxicol. Environ. Health Part A pmid:11086946
Bouchelouche K et al. The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle. 2003 J. Urol. pmid:12853847
Bouchelouche K and Bouchelouche P Cysteinyl leukotriene D4 increases human detrusor muscle responsiveness to histamine. 2006 J. Urol. pmid:16753444
Nishida T et al. Effects of leukotriene D4 on myocardial blood flow and high energy phosphate concentration in anesthetized dogs. 1994 Jpn. Circ. J. pmid:7967000
Fujita M et al. Cysteinyl leukotrienes induce nasal symptoms of allergic rhinitis via a receptor-mediated mechanism in guinea pigs. 1997 Jpn. J. Pharmacol. pmid:9469641
Arakida Y et al. In vivo pharmacologic profile of YM158, a new dual antagonist for leukotriene D4 and thromboxane A2 receptors. 2000 Jpn. J. Pharmacol. pmid:10887942
Kaminuma O et al. Inhibitory effect of a novel phosphodiesterase IV inhibitor, T-440, on antigen- and chemical mediator-induced bronchoconstrictions in guinea pigs in vivo. 1996 Jpn. J. Pharmacol. pmid:8902593
Tai S et al. Effect of leukotriene D4 on tracheal mucociliary transport velocity in quails. 1996 Jpn. J. Pharmacol. pmid:8866758
Mizutani N et al. Markedly increased nasal blockage by intranasal leukotriene D4 in an experimental allergic rhinitis model: contribution of dilated mucosal blood vessels. 2001 Jpn. J. Pharmacol. pmid:11459119
Nabe T et al. Comparison of cedar pollen-induced allergic rhinitis in passively and actively sensitized guinea pigs. 2001 Jpn. J. Pharmacol. pmid:11388645
Kano M Calcium-induced long-lasting potentiation of GABAergic currents in cerebellar Purkinje cells. 1994 Jpn. J. Physiol. pmid:7752516
Han HJ et al. Leukotriene D4 inhibits Na+ uptake through cAMP and PLC pathways in primary cultured renal proximal tubular cells. 1999 Kidney Blood Press. Res. pmid:10394108
Petric R and Ford-Hutchinson AW Elevated cysteinyl leukotriene excretion in experimental glomerulonephritis. 1994 Kidney Int. pmid:7853790
Drost AC et al. The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia. 2012 Leuk. Lymphoma pmid:21936770
Huang SC Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum. 2011 Life Sci. pmid:21396378
Beckh K et al. Effects of nitric oxide on leukotriene D4 decreased bile secretion in the perfused rat liver. 1997 Life Sci. pmid:9364199
Hisamatsu K and Nakajima M Pranlukast protects leukotriene C4- and D4-induced epithelial cell impairment of the nasal mucosa in vitro. 2000 Life Sci. pmid:11105993
Ruck LM et al. Synergistic antiallergic activity of combined histamine H1- and cysteinyl leukotriene1-receptor blockade in human bronchus. 2001 Life Sci. pmid:11432448
Lopes LR et al. Reduced inflammatory response in rats fed fat-rich diets: role of leukotrienes. 2000 Life Sci. pmid:10896024
Bäck M Functional characteristics of cysteinyl-leukotriene receptor subtypes. 2002 Life Sci. pmid:12072150
Luo H et al. [Changes of leukotriene D4 in nasal discharge and plasma of patients with persistent allergic rhinitis and the effects of antihistamine]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21761705